NEWARK, Del., Aug. 5, 2026 — The global Endovenous Laser Therapy (EVLT) Market is witnessing steady growth as healthcare providers increasingly adopt minimally invasive procedures for the treatment of varicose veins and chronic venous insufficiency. According to Future Market Insights (FMI), the market is projected to grow from USD 0.5 billion in 2025 to USD 1.1 billion by 2035, registering a 7.9% CAGR during the forecast period. Rising prevalence of venous disorders, growing patient preference for non-surgical treatments, expanding outpatient vascular procedures, and continuous innovation in laser technologies continue driving global market expansion.
Endovenous Laser Ablation (EVLA), also known by proprietary names such as EVLT®, ELVes®, and VeinSeal®, has become one of the most widely adopted minimally invasive treatments for varicose veins. Unlike traditional vein-stripping surgery, EVLA uses laser energy to seal diseased veins, allowing the body to naturally absorb the treated vessel while enabling faster recovery, minimal scarring, and reduced post-procedure discomfort.
The market is expected to create an absolute dollar opportunity of USD 0.6 billion between 2025 and 2035. Growth is supported by increasing awareness of minimally invasive vascular treatments, expanding hospital investments in laser-based technologies, and growing adoption of office-based vein treatment procedures.
👉 Get Detailed Market Forecasts, Competitive Benchmarking, and Pricing Trends
Key Endovenous Laser Therapy Market Highlights at a Glance
- Market Size (2025): USD 0.5 Billion
- Forecast Market Size (2035): USD 1.1 Billion
- Forecast Period: 2025–2035
- CAGR (2025–2035): 7.9%
- Absolute Dollar Opportunity: USD 0.6 Billion
- Leading Product Segment: Endovenous Laser Systems (54.3% Market Share in 2025)
- Leading End User: Hospitals (61.8% Market Share in 2025)
- Key Growth Regions: North America, Asia-Pacific, Europe
- Key Segments Covered: Product Type, End User, Region
Analyst Viewpoint
“The endovenous laser therapy market continues shifting toward minimally invasive vascular care as patients seek faster recovery and reduced procedural risks compared to conventional surgery. Advances in laser energy delivery, imaging guidance, and outpatient treatment capabilities are improving procedural outcomes while expanding adoption among vascular specialists. Continued innovation in laser platforms and greater awareness of chronic venous disease will remain key drivers of long-term market growth.” Anurag Sharma, Principal Analyst at Future Market Insights
Why Is the Endovenous Laser Therapy Market Growing?
Increasing prevalence of varicose veins, growing preference for minimally invasive procedures, and technological advancements in laser-based vascular treatment continue accelerating market growth.
Key Growth Drivers
- Rising prevalence of varicose veins and chronic venous insufficiency.
- Growing demand for minimally invasive treatment options.
- Increasing adoption of outpatient vascular procedures.
- Continuous innovation in endovenous laser technologies.
- Rising awareness of cosmetic and therapeutic vein treatments.
- Shorter recovery times compared to surgical vein stripping.
- Expanding healthcare investments in vascular care.
As healthcare providers increasingly prioritize minimally invasive interventions that improve patient outcomes and reduce hospital stays, endovenous laser therapy continues gaining widespread clinical acceptance.
Which Product Segment Leads the Endovenous Laser Therapy Market?
Endovenous Laser Systems dominate the market, accounting for 54.3% of total revenue in 2025.
Advanced laser systems provide precise thermal ablation of diseased veins while minimizing surrounding tissue damage, improving treatment effectiveness and patient comfort.
Product Segment Highlights
- Endovenous Laser Systems remain the leading product category.
- Advanced laser technologies improve procedural precision.
- Outpatient treatment supports broader adoption.
- Continuous product innovation enhances clinical outcomes.
Why Do Hospitals Dominate Market Demand?
Hospitals account for 61.8% of the market in 2025, reflecting their comprehensive vascular care capabilities, access to advanced imaging technologies, and availability of experienced vascular specialists.
Hospitals continue serving as primary treatment centers for complex venous disease while expanding minimally invasive vascular surgery programs.
End User Highlights
- Hospitals remain the leading treatment providers.
- Specialized vascular centers expand procedure volumes.
- Advanced imaging improves procedural safety.
- Minimally invasive techniques reduce patient recovery time.
How Is Endovenous Laser Therapy Transforming Varicose Vein Treatment?
Endovenous Laser Ablation (EVLA) has significantly transformed the management of varicose veins by providing an effective alternative to conventional surgery. The procedure uses laser energy delivered through a catheter to close abnormal veins, eliminating the need for surgical vein removal.
Patients typically undergo treatment in an outpatient setting under local anesthesia and are often able to resume normal daily activities shortly after the procedure. Compared with traditional surgical approaches, EVLA offers reduced recovery time, minimal scarring, lower post-operative discomfort, and high clinical success rates.
Although some patients may require additional procedures such as foam sclerotherapy or ambulatory phlebectomy to address residual veins, EVLA remains one of the most effective first-line treatments for symptomatic varicose veins.
Clinical Advantages
- Minimally invasive outpatient procedure.
- Faster recovery than conventional surgery.
- Reduced post-procedural pain and scarring.
- High long-term vein closure success rates.
- Improved patient quality of life.
Market Dynamics
Market Drivers
Growing incidence of chronic venous disease, increasing preference for minimally invasive vascular procedures, rising adoption of laser-based technologies, expanding healthcare infrastructure, favorable clinical outcomes, and growing awareness of vein health continue driving market growth.
Market Restraints
High equipment costs, reimbursement variability, limited access to specialized vascular centers, procedure-related complications, and competition from alternative therapies such as radiofrequency ablation (RFA) and foam sclerotherapy continue presenting challenges to wider market expansion.
Market Trends
Innovation continues reshaping the endovenous laser therapy industry.
Major trends include:
- High-efficiency laser fiber technologies.
- Office-based vein treatment expansion.
- Image-guided minimally invasive procedures.
- Improved radial laser fiber designs.
- Combination therapy with foam sclerotherapy.
- Enhanced patient recovery protocols.
- Advanced vascular imaging integration.
Regional Outlook
North America continues leading the global market through high adoption of minimally invasive vascular procedures, advanced healthcare infrastructure, favorable reimbursement for vein treatments, and growing patient awareness.
Europe remains a significant market due to increasing demand for minimally invasive venous therapies, while Asia-Pacific is expected to witness strong growth driven by improving healthcare infrastructure, rising vascular disease prevalence, and expanding access to advanced laser technologies.
Competitive Landscape
Competition remains focused on laser technology innovation, improved treatment efficiency, product safety, physician training, and expansion of minimally invasive vascular treatment portfolios.
Leading manufacturers continue investing in advanced laser systems, catheter technologies, and global distribution networks to strengthen their competitive position.
Key Companies
- AngioDynamics, Inc.
- Syneron Medical Ltd.
- Dornier MedTech GmbH
- Alma Lasers Ltd.
- Alna-Medical System GmbH
- LSO Medical
- Wontech Co., Ltd.
- intros Medical Laser GmbH
- Energist Ltd.
Frequently Asked Questions
- What is the projected size of the Endovenous Laser Therapy Market by 2035?
The global Endovenous Laser Therapy Market is projected to reach USD 1.1 billion by 2035, growing from USD 0.5 billion in 2025. - What is the expected CAGR of the Endovenous Laser Therapy Market?
The market is forecast to expand at a 7.9% CAGR between 2025 and 2035. - Which product segment dominates the Endovenous Laser Therapy Market?
Endovenous Laser Systems lead the market, accounting for 54.3% of total revenue in 2025. - Which end user holds the largest market share?
Hospitals remain the leading end-user segment with 61.8% of the global market in 2025. - What factors are driving market growth?
Rising prevalence of varicose veins, increasing demand for minimally invasive treatments, technological advancements in laser systems, expanding outpatient vascular procedures, favorable clinical outcomes, and growing awareness of vein health continue driving the global Endovenous Laser Therapy Market.
Related Reports:
- https://www.openpr.com/news/4595217/proteomics-market-trends-2026-ai-multi-omics-integration
- https://www.openpr.com/news/4595222/surface-disinfectant-market-2026-2036-infection-prevention
- https://www.openpr.com/news/4595228/pancreatic-beta-cell-therapy-market-size-share-forecast -stem
- https://www.openpr.com/news/4595231/precision-medicine-genomics-market-innovations-crispr-ai
- https://www.openpr.com/news/4595235/regenerative-medicine-scalable-manufacturing-market-to-reach
About Future Market Insights (FMI)
Future Market Insights (FMI) is a global market intelligence and consulting firm providing comprehensive market research, competitive intelligence, and strategic business insights across industries. The firm delivers detailed forecasts, technology analysis, and data-driven recommendations that support informed decision-making for manufacturers, investors, distributors, and policymakers worldwide.
For Press & Corporate Inquiries
Rahul Singh
AVP – Marketing and Growth Strategy
Future Market Insights, Inc.
+91 8600020075
For Sales – sales@futuremarketinsights.com
For Media – Rahul.singh@futuremarketinsights.com
For Web – https://www.futuremarketinsights.com
